LONDON (Reuters) - Representatives from U.S. drugmaker Pfizer and British pharmaceutical firm AstraZeneca will be called before a British parliamentary committee to discuss a potential takeover deal in the coming weeks, a committee spokesman said on Tuesday.
The Business, Innovation and Skills committee session will take place before May 26 and is likely to be in the next week, although a firm date had not been fixed, the spokesman said.
Last week lawmakers from the committee said they wanted to explore the impact of a potential $106 billion takeover of ASTRAZENECA (AZN.LO)by PFIZER (PFE.NY)on British interests.
(Reporting by William James; editing by Michael Holden)
Relacionados
- Pfizer gana un 15% menos a la espera del 'sí' de AstraZeneca
- Pfizer gana un 15,3% menos en el primer trimestre y confía en que AstraZeneca acepte negociar su oferta
- Economía.- Pfizer gana un 15,3% menos en el primer trimestre y confía en que AstraZeneca acepte negociar su oferta
- Pfizer dominará el 10% del mercado español si se hace con AstraZeneca
- Pfizer deberá subir su oferta o lanzar una opa hostil para hacerse con AstraZeneca
